OPEN ACCESS: All - Zosia Kmietowicz
- 1BMJ
The BMA has become the second organisation in a month to withdraw its support for a document outlining how healthcare professionals and the drug industry could collaborate.
In February, the Lancet said that it no longer backed the four page document,1 which was published in 2012 by the Ethical Standards in Health and Life Sciences Group (ESHLSG). The group is co-chaired by the president of the Royal College of Physicians, Richard Thompson, and the president of the Association of the British Pharmaceutical Industry, Deepak Khanna.2
Richard Horton, editor of the Lancet, said that the …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking